Demonstrated feasibility of effective DNA delivery with Company's xPhore™ nanoparticle technologyDNA delivery technology to be offered as GenePhore™ to biotech…
Operators highlight practical levers to speed AI, interoperability, and cyber resilience SAN ANTONIO, TX / ACCESS Newswire / November 3,…
CAMBRIDGE, Mass., Nov. 03, 2025 (GLOBE NEWSWIRE) -- Prime Medicine, Inc. (Nasdaq: PRME), a biotechnology company committed to delivering a…
SALT LAKE CITY, Oct. 31, 2025 /PRNewswire/ -- Co-Diagnostics, Inc. (NASDAQ: CODX), a molecular diagnostics company with a unique, patented platform for…
BOSTON, Oct. 31, 2025 /PRNewswire/ -- Ginkgo Bioworks (NYSE: DNA) today announced that the company has extended its multi-year strategic…
Unprecedented global turnout defined 2025 edition as 6,800 tech enterprises, 2,000 startups, 1,200 investors, and tech representatives from 180 nations…
Presentation and Q&A session scheduled for post-market on Thursday, November 6, 2025 BOSTON, Oct. 30, 2025 /PRNewswire/ -- Ginkgo Bioworks…
SALT LAKE CITY, Oct. 30, 2025 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX) (the "Company" or "Co-Dx"), a molecular diagnostics company with…
This guide informs consumers of franchise trends in health, wellness, and fitness by looking at how health-related franchises have adapted…
Dr. Hurvitz is an international expert in oncology and a recognized clinical research leader with extensive experience leading clinical trials…